SVB Leerink analyst Andrew Berens reiterates Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Outperform and maintains $30 price target.
Top Strategist Jon Wolfenbarger Warns Of Stock Market Crash And Year-Long Recession: ‘Market Highly Vulnerable To Falling To New Bear Lows’
Wolfenbarger, the founder of Bull and Bear Profits and a former JPMorgan banker, is particularly concerned about the consistent decline of The Conference Board's Leading Economic Index and the longest stretch of an inverted yield curve in more than half a century.
